Atypical Antipsychotics Induced Metabolic Syndrome/Atipik Antipsikotiklere Bagli Metabolik Sendrom

The use of atypical antipsychotics in patients with schizophrenia is tightly related to the metabolic abnormalities like weight gain, diabetes, dyslipidemia and/or hypertension. Beside of having unique receptor binding features, their heterogeneous receptor binding properties ara also involved in th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Psikiyatride güncel yaklaşimlar 2015-01, Vol.7 (1), p.81
Hauptverfasser: Demirel, Aysegul, Demirel, Omer Faruk, Ugur, Mufit
Format: Artikel
Sprache:tur
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page 81
container_title Psikiyatride güncel yaklaşimlar
container_volume 7
creator Demirel, Aysegul
Demirel, Omer Faruk
Ugur, Mufit
description The use of atypical antipsychotics in patients with schizophrenia is tightly related to the metabolic abnormalities like weight gain, diabetes, dyslipidemia and/or hypertension. Beside of having unique receptor binding features, their heterogeneous receptor binding properties ara also involved in the occurence of the metabolic side effects caused by atypical antipsychotics. It is striking that atypical antipschotics related metabolic side effects have the potential to influence each other in a negative way. Metabolic abnormalities related to atypical antipschotics do not only lead to increase in mortality, but also worsen clinical course and functionality of patients with schizophrenia. Thus, patients treated with atypical antipsychotics should be evaluated routinely with respect to their metabolic states. In this article, metabolic side effects of atypical antipsychotics and their mechanisms were investigated on pharmacological basis. Key words: Schizophrenia, metabolic syndrome, atypical antipsychotics. Sizofreni hastalarinda atipik antipsikotik ilaclarin kullaniminin kilo alimi, diyabet, dislipidemi ve/veya hipertansiyon gibi metabolik anormalliklerle siki sikiya iliskili oldugu bilinmektedir. Metabolik yan etkiler atipik antipsikotiklerin sadece kendilerine has reseptor baglama ozelliklerinin olmasinin disinda bu ilaclarin heterojen reseptor baglama ozellikleriyle de iliskili bulunmustur. Ayrica bu ajanlarla ortaya cikan metabolik yan etkilerin birbirlerini tetikleme potansiyelinin olmasi dikkati cekmektedir. Metabolik bozukluklarla iliskili olarak hastalarda sadece mortalitenin artmadigi, ayni zamanda klinigin kotulestigi ve islevselligin azaldigi da gozlemlenmektedir. Bu nedenlerle atipik antipsikotiklerle tedavi edilen hastalarin rutin olarak metabolik durumunun gozden gecirilmesi gereklidir. Bu derlemede atipik antipsikotiklerin metabolik yan etkileri ve mekanizmalari farmakolojik boyutta incelenmistir. Anahtar sozcukler: Sizofreni, metabolik sendrom, atipik antipsikotikler.
doi_str_mv 10.5455/cap.20140527123634
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A558814853</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A558814853</galeid><sourcerecordid>A558814853</sourcerecordid><originalsourceid>FETCH-LOGICAL-g673-5196fee67110f496816c853d7e2bceed4761e994d270a299a43301a32fc3aeae3</originalsourceid><addsrcrecordid>eNptjDtPwzAUhT2ARFX6B5gsMSf12_EYKh6VihjavXLsm2DyVBKG_HssqBAD5w5Huvq-g9AdJakUUm6dHVJGqCCSacq44uIKrSgnJiFKZjdoM00fJIYbzXi2QkU-L0NwtsF5N4dhWtx7Pwc34X3nPx14_AqzLfomOHxcOj_2LWzzCIb6IoQ68nUDI-AHWzXhV6jxEb6FW3Rd2maCzaXX6PT0eNq9JIe35_0uPySV0jyR1KgSQGlKSSmMyqhymeReAyscgBdaUTBGeKaJZcZYwTmhlrPScQsW-Brd_8xWtoFz6Mp-Hq1rw-TOuZRZRkWci1T6DxXPQxtc30EZ4v-P8AVGgWcQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Atypical Antipsychotics Induced Metabolic Syndrome/Atipik Antipsikotiklere Bagli Metabolik Sendrom</title><source>DOAJ Directory of Open Access Journals</source><creator>Demirel, Aysegul ; Demirel, Omer Faruk ; Ugur, Mufit</creator><creatorcontrib>Demirel, Aysegul ; Demirel, Omer Faruk ; Ugur, Mufit</creatorcontrib><description>The use of atypical antipsychotics in patients with schizophrenia is tightly related to the metabolic abnormalities like weight gain, diabetes, dyslipidemia and/or hypertension. Beside of having unique receptor binding features, their heterogeneous receptor binding properties ara also involved in the occurence of the metabolic side effects caused by atypical antipsychotics. It is striking that atypical antipschotics related metabolic side effects have the potential to influence each other in a negative way. Metabolic abnormalities related to atypical antipschotics do not only lead to increase in mortality, but also worsen clinical course and functionality of patients with schizophrenia. Thus, patients treated with atypical antipsychotics should be evaluated routinely with respect to their metabolic states. In this article, metabolic side effects of atypical antipsychotics and their mechanisms were investigated on pharmacological basis. Key words: Schizophrenia, metabolic syndrome, atypical antipsychotics. Sizofreni hastalarinda atipik antipsikotik ilaclarin kullaniminin kilo alimi, diyabet, dislipidemi ve/veya hipertansiyon gibi metabolik anormalliklerle siki sikiya iliskili oldugu bilinmektedir. Metabolik yan etkiler atipik antipsikotiklerin sadece kendilerine has reseptor baglama ozelliklerinin olmasinin disinda bu ilaclarin heterojen reseptor baglama ozellikleriyle de iliskili bulunmustur. Ayrica bu ajanlarla ortaya cikan metabolik yan etkilerin birbirlerini tetikleme potansiyelinin olmasi dikkati cekmektedir. Metabolik bozukluklarla iliskili olarak hastalarda sadece mortalitenin artmadigi, ayni zamanda klinigin kotulestigi ve islevselligin azaldigi da gozlemlenmektedir. Bu nedenlerle atipik antipsikotiklerle tedavi edilen hastalarin rutin olarak metabolik durumunun gozden gecirilmesi gereklidir. Bu derlemede atipik antipsikotiklerin metabolik yan etkileri ve mekanizmalari farmakolojik boyutta incelenmistir. Anahtar sozcukler: Sizofreni, metabolik sendrom, atipik antipsikotikler.</description><identifier>ISSN: 1309-0658</identifier><identifier>DOI: 10.5455/cap.20140527123634</identifier><language>tur</language><publisher>Anadolu Psikiyatri Dergisi</publisher><subject>Antipsychotic agents ; Care and treatment ; Health aspects ; Hypertension ; Mortality ; Schizophrenia</subject><ispartof>Psikiyatride güncel yaklaşimlar, 2015-01, Vol.7 (1), p.81</ispartof><rights>COPYRIGHT 2015 Anadolu Psikiyatri Dergisi</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids></links><search><creatorcontrib>Demirel, Aysegul</creatorcontrib><creatorcontrib>Demirel, Omer Faruk</creatorcontrib><creatorcontrib>Ugur, Mufit</creatorcontrib><title>Atypical Antipsychotics Induced Metabolic Syndrome/Atipik Antipsikotiklere Bagli Metabolik Sendrom</title><title>Psikiyatride güncel yaklaşimlar</title><description>The use of atypical antipsychotics in patients with schizophrenia is tightly related to the metabolic abnormalities like weight gain, diabetes, dyslipidemia and/or hypertension. Beside of having unique receptor binding features, their heterogeneous receptor binding properties ara also involved in the occurence of the metabolic side effects caused by atypical antipsychotics. It is striking that atypical antipschotics related metabolic side effects have the potential to influence each other in a negative way. Metabolic abnormalities related to atypical antipschotics do not only lead to increase in mortality, but also worsen clinical course and functionality of patients with schizophrenia. Thus, patients treated with atypical antipsychotics should be evaluated routinely with respect to their metabolic states. In this article, metabolic side effects of atypical antipsychotics and their mechanisms were investigated on pharmacological basis. Key words: Schizophrenia, metabolic syndrome, atypical antipsychotics. Sizofreni hastalarinda atipik antipsikotik ilaclarin kullaniminin kilo alimi, diyabet, dislipidemi ve/veya hipertansiyon gibi metabolik anormalliklerle siki sikiya iliskili oldugu bilinmektedir. Metabolik yan etkiler atipik antipsikotiklerin sadece kendilerine has reseptor baglama ozelliklerinin olmasinin disinda bu ilaclarin heterojen reseptor baglama ozellikleriyle de iliskili bulunmustur. Ayrica bu ajanlarla ortaya cikan metabolik yan etkilerin birbirlerini tetikleme potansiyelinin olmasi dikkati cekmektedir. Metabolik bozukluklarla iliskili olarak hastalarda sadece mortalitenin artmadigi, ayni zamanda klinigin kotulestigi ve islevselligin azaldigi da gozlemlenmektedir. Bu nedenlerle atipik antipsikotiklerle tedavi edilen hastalarin rutin olarak metabolik durumunun gozden gecirilmesi gereklidir. Bu derlemede atipik antipsikotiklerin metabolik yan etkileri ve mekanizmalari farmakolojik boyutta incelenmistir. Anahtar sozcukler: Sizofreni, metabolik sendrom, atipik antipsikotikler.</description><subject>Antipsychotic agents</subject><subject>Care and treatment</subject><subject>Health aspects</subject><subject>Hypertension</subject><subject>Mortality</subject><subject>Schizophrenia</subject><issn>1309-0658</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptjDtPwzAUhT2ARFX6B5gsMSf12_EYKh6VihjavXLsm2DyVBKG_HssqBAD5w5Huvq-g9AdJakUUm6dHVJGqCCSacq44uIKrSgnJiFKZjdoM00fJIYbzXi2QkU-L0NwtsF5N4dhWtx7Pwc34X3nPx14_AqzLfomOHxcOj_2LWzzCIb6IoQ68nUDI-AHWzXhV6jxEb6FW3Rd2maCzaXX6PT0eNq9JIe35_0uPySV0jyR1KgSQGlKSSmMyqhymeReAyscgBdaUTBGeKaJZcZYwTmhlrPScQsW-Brd_8xWtoFz6Mp-Hq1rw-TOuZRZRkWci1T6DxXPQxtc30EZ4v-P8AVGgWcQ</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Demirel, Aysegul</creator><creator>Demirel, Omer Faruk</creator><creator>Ugur, Mufit</creator><general>Anadolu Psikiyatri Dergisi</general><scope/></search><sort><creationdate>20150101</creationdate><title>Atypical Antipsychotics Induced Metabolic Syndrome/Atipik Antipsikotiklere Bagli Metabolik Sendrom</title><author>Demirel, Aysegul ; Demirel, Omer Faruk ; Ugur, Mufit</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g673-5196fee67110f496816c853d7e2bceed4761e994d270a299a43301a32fc3aeae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>tur</language><creationdate>2015</creationdate><topic>Antipsychotic agents</topic><topic>Care and treatment</topic><topic>Health aspects</topic><topic>Hypertension</topic><topic>Mortality</topic><topic>Schizophrenia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Demirel, Aysegul</creatorcontrib><creatorcontrib>Demirel, Omer Faruk</creatorcontrib><creatorcontrib>Ugur, Mufit</creatorcontrib><jtitle>Psikiyatride güncel yaklaşimlar</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Demirel, Aysegul</au><au>Demirel, Omer Faruk</au><au>Ugur, Mufit</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Atypical Antipsychotics Induced Metabolic Syndrome/Atipik Antipsikotiklere Bagli Metabolik Sendrom</atitle><jtitle>Psikiyatride güncel yaklaşimlar</jtitle><date>2015-01-01</date><risdate>2015</risdate><volume>7</volume><issue>1</issue><spage>81</spage><pages>81-</pages><issn>1309-0658</issn><abstract>The use of atypical antipsychotics in patients with schizophrenia is tightly related to the metabolic abnormalities like weight gain, diabetes, dyslipidemia and/or hypertension. Beside of having unique receptor binding features, their heterogeneous receptor binding properties ara also involved in the occurence of the metabolic side effects caused by atypical antipsychotics. It is striking that atypical antipschotics related metabolic side effects have the potential to influence each other in a negative way. Metabolic abnormalities related to atypical antipschotics do not only lead to increase in mortality, but also worsen clinical course and functionality of patients with schizophrenia. Thus, patients treated with atypical antipsychotics should be evaluated routinely with respect to their metabolic states. In this article, metabolic side effects of atypical antipsychotics and their mechanisms were investigated on pharmacological basis. Key words: Schizophrenia, metabolic syndrome, atypical antipsychotics. Sizofreni hastalarinda atipik antipsikotik ilaclarin kullaniminin kilo alimi, diyabet, dislipidemi ve/veya hipertansiyon gibi metabolik anormalliklerle siki sikiya iliskili oldugu bilinmektedir. Metabolik yan etkiler atipik antipsikotiklerin sadece kendilerine has reseptor baglama ozelliklerinin olmasinin disinda bu ilaclarin heterojen reseptor baglama ozellikleriyle de iliskili bulunmustur. Ayrica bu ajanlarla ortaya cikan metabolik yan etkilerin birbirlerini tetikleme potansiyelinin olmasi dikkati cekmektedir. Metabolik bozukluklarla iliskili olarak hastalarda sadece mortalitenin artmadigi, ayni zamanda klinigin kotulestigi ve islevselligin azaldigi da gozlemlenmektedir. Bu nedenlerle atipik antipsikotiklerle tedavi edilen hastalarin rutin olarak metabolik durumunun gozden gecirilmesi gereklidir. Bu derlemede atipik antipsikotiklerin metabolik yan etkileri ve mekanizmalari farmakolojik boyutta incelenmistir. Anahtar sozcukler: Sizofreni, metabolik sendrom, atipik antipsikotikler.</abstract><pub>Anadolu Psikiyatri Dergisi</pub><doi>10.5455/cap.20140527123634</doi></addata></record>
fulltext fulltext
identifier ISSN: 1309-0658
ispartof Psikiyatride güncel yaklaşimlar, 2015-01, Vol.7 (1), p.81
issn 1309-0658
language tur
recordid cdi_gale_infotracmisc_A558814853
source DOAJ Directory of Open Access Journals
subjects Antipsychotic agents
Care and treatment
Health aspects
Hypertension
Mortality
Schizophrenia
title Atypical Antipsychotics Induced Metabolic Syndrome/Atipik Antipsikotiklere Bagli Metabolik Sendrom
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T16%3A42%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Atypical%20Antipsychotics%20Induced%20Metabolic%20Syndrome/Atipik%20Antipsikotiklere%20Bagli%20Metabolik%20Sendrom&rft.jtitle=Psikiyatride%20g%C3%BCncel%20yakla%C5%9Fimlar&rft.au=Demirel,%20Aysegul&rft.date=2015-01-01&rft.volume=7&rft.issue=1&rft.spage=81&rft.pages=81-&rft.issn=1309-0658&rft_id=info:doi/10.5455/cap.20140527123634&rft_dat=%3Cgale%3EA558814853%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A558814853&rfr_iscdi=true